Latest Competition News

Orora Limited reported a robust 32.2% rise in underlying net profit after tax for the half-year ended December 2025, underpinned by strong volume growth in its Cans segment and operational efficiencies across its glass businesses. The company also completed a $227.4 million share buyback in 2025 and announced a fresh $270 million on-market buyback program.

Orora Limited has announced an ordinary unfranked dividend of AUD 0.05 per share for the six months ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Orora Limited reported a statutory profit of $58.9 million for the half-year ended December 2025, driven by operational improvements despite significant restructuring costs. The company declared an interim dividend and announced a fresh share buy-back program.

Breville Group Limited has reported a record half-year revenue of $1.1 billion, driven by strong coffee sales and new market growth, while successfully managing US tariff impacts to maintain flat EBIT year-on-year.

Breville Group Limited has announced a fully franked ordinary dividend of AUD 0.19 per share for the six months ending December 2025, signaling steady returns for shareholders.

Breville Group Limited has reported a record half-year revenue of $1.1 billion for the six months ended December 2025, alongside modest profit growth and a raised interim dividend.

Temple & Webster Group Limited reported a robust 20% revenue increase to $376 million in the first half of FY26, maintaining momentum towards its $1 billion revenue target by FY28. The company’s strategic investments in AI, exclusive products, and new markets like New Zealand underpin its expanding market presence.

Oneview Healthcare reported a robust 21% increase in revenue for FY2025, driven by recurring revenue growth and new customer acquisitions. The company is advancing AI-powered solutions and targeting operational breakeven in 2026.

Patrys Limited has appointed Dr Samantha South as its new CEO, aiming to leverage her biotech expertise to fast-track clinical development and commercialisation of its therapeutic antibody pipeline.

Insurance Australia Group Limited (IAG) has announced a quarterly dividend of AUD 1.5565 per security on its Capital Notes 3, payable mid-March 2026 with partial franking.

IAG’s 1H26 results reveal a 35% drop in net profit after tax due to severe weather costs from its RACQI acquisition, yet underlying insurance profit rose 7.6%, supported by solid premium growth and a $200 million share buyback.

EROAD Limited’s CEO Mark Heine has announced his resignation effective June 2026, concluding an 11-year tenure marked by significant company growth across multiple regions.